Evidence map›Paper›PMID 37305890›Full record

ArticleClinical case reports2023

A rare case of dentinogenic ghost cell tumor with concomitant odontoma.

Tatsuo Okui, Reon Morioka, Teruaki Iwahashi, Yuhei Matsuda, Shinji Ishizuka, Satoe Okuma, Hiroto Tatsumi, Takahiro Kanno

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tatsuo OkuiDepartment of Oral and Maxillofacial Surgery Shimane University Faculty of Medicine Izumo Japan.ORCID https://orcid.org/0000-0002-7640-3274
Reon MoriokaDepartment of Oral and Maxillofacial Surgery Shimane University Faculty of Medicine Izumo Japan.
Teruaki IwahashiDepartment of Surgical Pathology Shimane University Faculty of Medicine Izumo Japan.
Yuhei MatsudaDepartment of Oral and Maxillofacial Surgery Shimane University Faculty of Medicine Izumo Japan.
Shinji IshizukaDepartment of Oral and Maxillofacial Surgery Shimane University Faculty of Medicine Izumo Japan.
Satoe OkumaDepartment of Oral and Maxillofacial Surgery Shimane University Faculty of Medicine Izumo Japan.
Hiroto TatsumiDepartment of Oral and Maxillofacial Surgery Shimane University Faculty of Medicine Izumo Japan.
Takahiro KannoDepartment of Oral and Maxillofacial Surgery Shimane University Faculty of Medicine Izumo Japan.
Shimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: A case of dentinogenic ghost cell tumor occurring simultaneously with a clinically diagnosed odontoma. The occurrence of epithelial and mesenchymal tumors at the same site is very rare, but should be kept in mind during pathological diagnosis. Abstract: Dentinogenic ghost cell tumor (DGCT) is a rare and benign odontogenic tumor composed of ghost cells, calcified tissue, and dentin. We present an extremely rare case of a 32-year-old female who was clinically diagnosed with an odontoma presenting with a painless swelling in her maxilla. Radiographic examination showed a well-defined radiolucent lesion with tooth-like calcified areas. The tumor was resected under general anesthesia. No recurrence was noted at the 12-month follow-up. Histopathological examination of the surgically resected tumor yielded a diagnosis of DGCT with odontoma.

Indexed as

dentinogenic ghost cell tumorodontogenic tumorodontoma

Identifiers

PMID37305890
PMCPMC10248198
OpenAlexW4379882793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.